Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Kisspeptin-10

KP-10, Metastin (45-54), Kisspeptin-10 (human), KiSS-1

Quick Stats
Studies 877
Trials 47
Score 2
2006 pubmed 63 citations

GPR54 and KiSS-1: role in the regulation of puberty and reproduction.

Kuohung. Wendy W; Kaiser. Ursula B UB

Key Findings

  • Mutations that disable GPR54 cause delayed puberty (IHH) in humans and prevent puberty in mice
  • Kisspeptin directly stimulates GnRH neurons, leading to LH and FSH release
  • Levels of kisspeptin and GPR54 rise in the hypothalamus at the onset of puberty

Practical Outcomes

  • The findings confirm kisspeptin’s central role in puberty and suggest it could become a target for future fertility or anti‑cancer drugs, but there are no immediate, safe ways for self‑experimentation or dosage recommendations.

Summary

This study shows that the kisspeptin‑GPR54 system is essential for starting puberty by activating the brain's GnRH neurons, which then trigger hormone release. While it explains how the pathway works, it doesn’t give any dosing or protocol details for everyday use.

Abstract

The finding of inactivating mutations in GPR54 in IHH patients and the lack of reproductive maturation of the GPR54 null mouse have uncovered a previously unrecognized role for GPR54 and KiSS-1 in the physiologic regulation of puberty and reproduction. This newly identified function for GPR54 and its cognate ligand, kisspeptin, has led to additional studies that have localized GPR54 and KiSS-1 mRNA in the hypothalamus, colocalized GPR54 in GnRH neurons, demonstrated GnRH-dependent activation of LH and FSH release by kisspeptin, and shown increased hypothalamic KiSS-1 and GPR54 mRNA levels at the time of puberty. Taken together, these findings establish the role of the kisspeptin-GPR54 system in the stimulation of GnRH neurons during puberty. The mechanisms by which kisspeptin activates GnRH release, as well as the trigger for this pathway at the onset of puberty, are yet to be elucidated. In the future, modulators of GPR54 activity, including kisspeptin, may prove valuable in clinical applications in the fields of both cancer therapy and reproductive medicine.

Study Information

Provider

pubmed

Year

2006

Date

2007-01-06T00:00:00.000Z

DOI

10.1007/s11154-006-9020-2

Citations

63

References

50